The first TG Therapeutics trade was made in Q4 2020.
Since then Ken Fisher bought shares three more times and sold shares on three occasions. The investor completely sold their stake between Q1 2022 and Q2 2022.
Avg closing price
Price range
Sold -1.51 Million shares
Q2 2022
Avg closing price
$6.24
Price range
$3.74
-
$10.66
Sold 0.2% shares (-2.55 Thousand shares)
Q1 2022
Avg closing price
$11.57
Price range
$7.81
-
$20.45
Increased shares by 71.8% (+633 Thousand shares)
Q4 2021
Avg closing price
$25.96
Price range
$15.20
-
$35.51
Increased shares by 95.2% (+430 Thousand shares)
Q3 2021